A new phase of trials to test two promising HIV vaccines began last week in London and Oxford. The vaccines—one made of naked DNA, the other a weakened pox virus—contain genes from a common strain of HIV in Africa, and should provoke an immune response that fends off the virus itself. Volunteers are receiving different combinations of the vaccines or a placebo. Teams at Imperial College in London and the Medical Research Council’s Human Immunology Unit in Oxford hope to recruit 120 volunteers aged 18 to 60, who must be HIV-negative.
More from New Ä¢¹½Ö±²¥
Explore the latest news, articles and features
Humans
Homo erectus survived on mainland Asia 215,000 years longer than we thought
News
Technology
Quantum trick lets you share your location super securely
News
Space
Cannibal giant star caught devouring its companion in super-rare event
News
Mind
Can technology recreate the mental health benefits of psychedelic trips?
Features
Popular articles
Trending New Ä¢¹½Ö±²¥ articles